Dear Authors, Reviewers, and Editors,  

Are you curious about what’s trending in Acta Neuropsychiatrica?  

Discover the most talked-about research of 2024, showcasing what your peers are reading, citing, and discussing.  

These articles highlight emerging topics and key insights across basic and clinical investigation, offering a snapshot of the field’s latest advancements.  

Check what is shaping the future of Psychiatry and stay connected.  

📈 Most Downloaded Papers  

1. Cannabis-induced psychotic disorder with onset during withdrawal: a brief report of emerging evidence  https://doi.org/10.1017/neu.2023.60  
2. A single dose of cocaine raises SV2A density in hippocampus of adolescent rats  https://doi.org/10.1017/neu.2023.14  
3. Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders https://doi.org/10.1017/neu.2023.25  
4. Cannabidiol negatively modulates adenosine A2A receptor functioning in living cells  https://doi.org/10.1017/neu.2023.30  
5. Bradykinin actions in the central nervous system: historical overview and psychiatric implications  https://doi.org/10.1017/neu.2023.57  

🏅 Most Cited Papers  

1. Adverse childhood experiences and reoccurrence of illness impact the gut microbiome, which affects suicidal behaviours and the phenome of major depression: towards enterotypic phenotypes  https://doi.org/10.1017/neu.2023.21  
2. Apathy associated with antidepressant drugs: a systematic review  https://doi.org/10.1017/neu.2023.6  
3. Wearables measuring electrodermal activity to assess perceived stress in care: a scoping review  https://doi.org/10.1017/neu.2023.19  
4. 4. Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders  https://doi.org/10.1017/neu.2023.25  
5. Group independent components underpin responses to items from a depression scale  https://doi.org/10.1017/neu.2023.22  

🌟 Top @Altimetric Scores  

1. The influence of peer non-suicidal self-harm on young adults’ urges to self-harm: experimental study  https://doi.org/10.1017/neu.2023.51  
2. A double-blind, placebo-controlled, randomised withdrawal study of adjunctive brexpiprazole maintenance treatment for major depressive disorder  https://doi.org/10.1017/neu.2024.32  
3. On hallucinations and memory: the relationship between hallucinations and autobiographical overgenerality in Alzheimer’s Disease  https://doi.org/10.1017/neu.2024.7  
4. Reactivation of herpesvirus type 6 and IgA/IgM-mediated responses to activin-A underpin long COVID, including affective symptoms and chronic fatigue syndrome  https://doi.org/10.1017/neu.2024.10  
5. Aggressive behaviours associated with MDMA and psychedelics: a narrative review  https://doi.org/10.1017/neu.2024.3  

We’re delighted to announce that all articles accepted for publication in Acta Neuropsychiatrica will now be fully Open Access (Gold OA). We have an OA option for every author: the costs of open access publication will be covered through agreements between the publisher and the author’s institution, payment of APCs from grant or other funds, or else waived entirely, ensuring every author can publish and enjoy the benefits of OA. See our homepage for full details.  

https://www.cambridge.org/core/journals/acta-neuropsychiatrica  

I would like to take this opportunity to express our profound gratitude to our Editors, Editorial Board and Reviewers, whose expertise and dedication are integral to the rigorous peer-review process, as well as all Authors, who trust their work to our journal. Your invaluable contributions uphold the journal's high standards and ensure the publication of impactful, cutting-edge research.  

On behalf of the entire editorial team,  

Warm regards,  

Gregers Wegener
Editor-in-chief of Acta Neuropsychiatrica